Adalvo Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 283

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 4

  • Investments
  • 1

Adalvo General Information

Description

Operator of a pharmaceutical company that focuses primarily on the sale of services to companies. The company operates according to a business model and offers smart services to form a network of partners to achieve its goals, thus delivering high-quality products and services to partners.

Contact Information

Website
www.adalvo.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Malta Life Sciences Park, Building 1
  • Level 4, Sir Temi Zammit Buildings, San Gwann Industrial Estate
  • San Gwann, SGN 3000
  • Malta
+356 2248
Primary Industry
Pharmaceuticals
Corporate Office
  • Malta Life Sciences Park, Building 1
  • Level 4, Sir Temi Zammit Buildings, San Gwann Industrial Estate
  • San Gwann, SGN 3000
  • Malta
+356 2248

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adalvo Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Adalvo‘s full profile, request access.

Request a free trial

Adalvo Patents

Adalvo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026022235-A1 A fixed-dose pharmaceutical composition comprising (2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid and (6r,12ar)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione Pending 24-Jul-2024
EP-4684777-A1 A fixed-dose pharmaceutical composition comprising (2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid and (6r,12ar)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino{1',2:1,6]pyrido[3,4-b]indole-1,4-dione Pending 24-Jul-2024
EP-4780459-A1 Pharmaceutical compositions comprising riociguat as active ingredient and other relevant excipients Pending 20-Sep-2023
WO-2025063911-A1 Pharmaceutical compositions comprising riociguat as active ingredient and other relevant excipients Inactive 20-Sep-2023
EP-4431083-A1 Formulation of dalbavancin Inactive 16-Mar-2023 A61K9/0019
To view Adalvo’s complete patent history, request access »

Adalvo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adalvo Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Adalvo‘s full profile, request access.

Request a free trial

Adalvo Investments (1)

Adalvo’s most recent deal was a Buyout/LBO with Onsolis. The deal was made on 02-Aug-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Onsolis 02-Aug-2023 Buyout/LBO Buildings and Property
To view Adalvo’s complete investments history, request access »

Adalvo FAQs

  • When was Adalvo founded?

    Adalvo was founded in 2018.

  • Where is Adalvo headquartered?

    Adalvo is headquartered in San Gwann, Malta.

  • What is the size of Adalvo?

    Adalvo has 283 total employees.

  • What industry is Adalvo in?

    Adalvo’s primary industry is Pharmaceuticals.

  • Is Adalvo a private or public company?

    Adalvo is a Private company.

  • What is Adalvo’s current revenue?

    The current revenue for Adalvo is .

  • Who are Adalvo’s investors?

    EQT and Aztiq Pharma Partners have invested in Adalvo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process